NCT05245357

Brief Summary

Dietary incorporation of pulse crops may be an effective way to lower unhealthy elevations in serum bile acids. These elevations play a direct role in promoting obesity-related diseases estimated to be present in about one third of the US adult population, including non-alcoholic fatty liver disease and type 2 diabetes. The overarching hypothesis for this study is that pulse consumption increases bile acid secretion and excretion, which will decrease toxicity linked to excess accumulation of bile in the liver, improve metabolism, and lower resulting levels of bile acids in the serum. In direct alignment with the USDA-AFRI Food, Safety, Nutrition, and Health priority to address obesity and related chronic disease with increased fruit and vegetable consumption and also with the American Pulse Association call to investigate the impact of regular pulse consumption on human physical well- being, the long-term research goal of this study is to establish effective and practical therapeutic strategies utilizing dietary incorporation of pulse crops to prevent or reverse obesity driven diseases. The specific objectives in this proposal are to:

  1. 1.determine the impact of acute lentil ingestion on serum postprandial bile acid responses and composition in a human cohort with obesity, and
  2. 2.determine the impact of daily lentil consumption for 12 weeks on serum fasting and postprandial bile acid concentrations and composition in an overweight or obese cohort with elevated postprandial triglycerides.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 17, 2022

Completed
7 days until next milestone

Study Start

First participant enrolled

February 24, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

May 6, 2023

Status Verified

May 1, 2023

Enrollment Period

2.2 years

First QC Date

January 31, 2022

Last Update Submit

May 2, 2023

Conditions

Outcome Measures

Primary Outcomes (8)

  • Postprandial Bile Acid Response to High-Fat Meal

    Area under the curve for bile acid concentration after consuming a meal containing 40g fat

    1 day

  • Peak Bile Acid Response to High-Fat Meal

    Greatest change in bile acid concentration after consuming a meal containing 40g fat

    1 day

  • Postprandial Triglyceride Response to High-Fat Meal

    Area under the curve for triglcyerides concentration after consuming a meal containing 40g fat

    1 day

  • Peak Triglyceride Response to High-Fat Meal

    Greatest change in triglycerides concentration after consuming a meal containing 40g fat

    1 day

  • Postprandial Serum Inflammatory Cytokine (tumor necrosis factor-alpha, interleukin-(IL)1beta, IL-6, IL-10, IL-17, IL-23, interferon-gamma, and granulocyte macrophage-colony stimulating factor; all in pg/ml) Response to High-fat Meal

    Area under the curve for inflammatory cytokine (tumor necrosis factor-alpha, interleukin-(IL)1beta, IL-6, IL-10, IL-17, IL-23, interferon-gamma, and granulocyte macrophage-colony stimulating factor; all in pg/ml) concentrations after consuming a meal containing 40 g of fat

    1 day

  • Postprandial Serum Metabolite Response (untargeted) to a High-Fat Meal

    Changes in concentrations of metabolites measured with untargeted liquid chromatography mass spectrometry (LCMS) metabolomic analysis after consuming a meal containing 40g of fat

    1 day

  • Fasting Serum Metabolite Response (untargeted) to a High-Fat Meal

    Changes in concentrations of metabolites measured with untargeted liquid chromatography mass spectrometry (LCMS) metabolomic analysis before consuming a meal containing 40g of fat

    1 day

  • Gut Microbiome Composition

    Relative abundance of operational taxonomic units of microbes measured from fecal samples

    1 day

Secondary Outcomes (6)

  • Body Composition

    1 day

  • Visceral Adipose Tissue

    1 day

  • Body Mass Index

    1 day

  • Habitual Diet

    1 month

  • Acute Diet

    1 day

  • +1 more secondary outcomes

Study Arms (2)

Lentil, then Control

EXPERIMENTAL

Participants first received a meal with 140 g of lentils in the morning. After a washout period of at least 7 days, they then received a meal with 0 g of lentils in the morning.

Behavioral: LentilBehavioral: Control

Control, then Lentil

EXPERIMENTAL

Participants first received a meal with 0 g of lentils in the morning. After a washout period of at least 7 days, they then received a meal with 140 g of lentils in the morning.

Behavioral: LentilBehavioral: Control

Interventions

LentilBEHAVIORAL

Participants in the lentil arm of the study will consume a meal containing 140 g of lentils for breakfast one morning.

Control, then LentilLentil, then Control
ControlBEHAVIORAL

Participants in the control arm of the study will consume a meal containing 0 g of lentils for breakfast one morning.

Control, then LentilLentil, then Control

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age
  • Body Mass Index greater than 27 kg/m\^2

You may not qualify if:

  • taking medication that will influence cholesterol, lipids, or inflammation
  • a gallbladder condition or have had the gallbladder removed
  • allergy to wheat, dairy, or legumes
  • pregnant or lactating
  • have been on a ketogenic or paleo diet in the past 6 weeks
  • have been on antibiotics in the past 90 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nutrition Research Laboratory

Bozeman, Montana, 59717, United States

RECRUITING

MeSH Terms

Conditions

InflammationHypertriglyceridemiaMetabolic DiseasesLipid Metabolism DisordersHyperlipidemias

Interventions

lentil lectin

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsDyslipidemiasNutritional and Metabolic Diseases

Study Officials

  • Mary P Miles, PhD

    Montana State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mary P Miles, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Lentil and Control meals were designed to be comparable in taste and appearance. The meals are prepared and coded prior to receipt by the research team. Randomization is for order of coded meals.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: The design is 2 x 2 crossover design, where the overweight and obese adults without Type 2 Diabetes will be randomized into Control or Lentil
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2022

First Posted

February 17, 2022

Study Start

February 24, 2022

Primary Completion

May 1, 2024

Study Completion

May 1, 2024

Last Updated

May 6, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations